Drug & medication recalls Moderate risk

TACROLIMUS 0 recalled over sterility concerns

Recall date
December 22, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Pharmacy Innovations recalls TACROLIMUS 0.03% OPH SOLUTION TACROLIMUS 0.1% (1ML DROPTAINER) OPH SOLUTION TACROLIMUS -CORN OIL- 0.03% OPH SOLUTION TA…
Recall number
D-0237-2023
FDA classification
Class II
Brand / firm
Pharmacy Innovations
Sold / distributed
Nationwide in the USA

Why it was recalled

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

TACROLIMUS 0.03% OPH SOLUTION TACROLIMUS 0.1% (1ML DROPTAINER) OPH SOLUTION TACROLIMUS -CORN OIL- 0.03% OPH SOLUTION TACROLIMUS-VET- 0.02% (10ML DROPPER) OPHTHALMIC TACROLIMUS-VET- 0.02% (15ML DROPPER) OPHTHALMIC TACROLIMUS-VET- 0.02% (5ML DROPPER) OPHTHALMIC TACROLIMUS-VET- 0.03% (10ML DROPPER) OPHTHALMIC, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

Get recall alerts

Free email alert whenever Pharmacy Innovations has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Pharmacy Innovations